Submit Abstract
First Round Abstract Submission Deadline:
July 13, 2026
ABSTRACT SUBMISSION
Notes:
To ensure high-quality submissions, we require all abstracts to undergo peer-review. The scientific committee's decision is final. Please carefully review your abstract before submitting.
Scientific Sessions
- Current State and Future Directions in Cell & Gene Therapy
- Translational Research Strategies for Accelerating Clinical Development
- Advances in Gene Editing Technologies and Therapeutic Applications
- Stem Cell and Regenerative Medicine: Clinical Translation and Emerging Therapies
- Cell Reprogramming and Next-Generation Regenerative Approaches
- RNA-Based Therapeutics and Gene Modulation Technologies
- Non-Viral and Novel Gene Delivery Platforms
- Personalized and Precision Cell & Gene Therapies
- Translational Challenges in Rare and Genetic Diseases
- Clinical Development of Cell & Gene Therapies for Oncology
- Neurodegenerative and Neuromuscular Disease Therapeutics
- Emerging Therapeutic Applications Beyond Rare Diseases
- Real-World Evidence and Long-Term Patient Outcomes
- Clinical Trial Design and Patient-Centric Development Strategies
- CRISPR, Base Editing, Prime Editing and Beyond
- Precision Genome Engineering for Next-Generation Therapies
- In Vivo vs Ex Vivo Gene Editing Strategies
- Engineering Immune Cells: CAR-T, CAR-NK, TCR-T and Beyond
- Multiplex Gene Editing and Synthetic Biology Approaches
- Gene Editing for Hematological and Inherited Disorders
- Engineering Stem Cells for Regenerative Applications
- Novel Vector Technologies and Targeted Delivery Systems
- AI-Driven Target Identification and Therapeutic Design
- Gene Editing Safety, Off-Target Analysis and Risk Mitigation
- Translational Models for Gene Editing and Cell Therapy Development
- Emerging Genome Engineering Platforms and Future Technologies
- Clinical Trial Design for Cell & Gene Therapies
- Patient Recruitment, Diversity and Retention Strategies
- Biomarkers, Companion Diagnostics and Patient Selection
- Clinical Safety Monitoring and Long-Term Follow-Up
- Real-World Evidence and Post-Marketing Data Generation
- Translational Medicine Approaches for Accelerating Development
- Clinical Success Stories and Lessons Learned
- Global Clinical Development Strategies
- Digital Health and AI in Clinical Trial Management
- Patient Access and Treatment Adoption
- Scaling Cell & Gene Therapy Manufacturing for Commercial Success
- Process Development and Tech Transfer Strategies
- Viral Vector Manufacturing and Capacity Expansion
- Next-Generation Non-Viral Manufacturing Platforms
- Automation, Robotics and Digital Manufacturing
- AI and Data Analytics in Bioprocess Optimization
- GMP Compliance and Quality-by-Design Approaches
- Quality Control, Release Testing and Comparability
- Closed-System Manufacturing Technologies
- Decentralized and Point-of-Care Manufacturing Models
- Cold Chain Logistics and Global Distribution Strategies
- Supply Chain Resilience and Risk Management
- CDMO Partnerships and Outsourcing Models
- Cost Reduction and Manufacturing Economics
- Sustainable Manufacturing for Advanced Therapies
- Global Regulatory Landscape for Cell & Gene Therapies
- FDA, EMA and International Regulatory Perspectives
- Accelerated Approval Pathways and Expedited Programs
- Regulatory Considerations for Gene Editing Technologies
- CMC Strategies for Regulatory Success
- Pharmacovigilance and Long-Term Safety Monitoring
- Market Access and Reimbursement Strategies
- Value Demonstration and Health Economics
- Innovative Pricing Models for Advanced Therapies
- Commercial Launch Readiness and Market Entry Planning
- Intellectual Property, Licensing and Technology Transfer
- Strategic Partnerships, M&A and Investment Trends
- Venture Capital and Funding Opportunities in Cell & Gene Therapy
- Commercial Success Stories and Lessons from Approved Products
- Academia–Industry Collaboration Models
- Building Successful Translational Research Ecosystems
- Biotech Startups and Emerging Innovation Platforms
- Investment Trends in Cell & Gene Therapy
- Strategic Alliances and Partnering Opportunities
- Technology Commercialization and Licensing Strategies
- Public-Private Partnerships in Advanced Therapeutics
- Future Outlook: The Next Decade of Cell & Gene Therapy